Jaime Escobedo
Founder at Nirogy Therapeutics, Inc.
Network origin in Jaime Escobedo first degree
Entity | Entity type | Industry | |
---|---|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Nirogy Therapeutics, Inc.
Nirogy Therapeutics, Inc. BiotechnologyHealth Technology Nirogy Therapeutics, Inc. is an American biotechnology company that operates in the healthcare industry. The company is based in N/A. The company was founded in 2014 by Vincent Sandanayaka, Jaime Escobedo. Simon C. Pedder has been the CEO of the company since 2022.
6
| Holding Company | Biotechnology | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jaime Escobedo via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
CELGENE | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
IMMUNOMEDICS, INC. | Biotechnology | Corporate Officer/Principal | |
TRANSGENE | Biotechnology | Chief Executive Officer | |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
HUMANIGEN, INC. | Biotechnology | Director/Board Member | |
Millendo Therapeutics US, Inc.
Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics US, Inc. engages in the development of novel treatment for adrenal cancer. It focuses on developing a portfolio of disease-modifying treatments for endocrine disorders caused by hormone dysregulation. The company was founded by Raili E. Kerppola, Julia C. Owens, and Gary D. Hammer in January 2012 and is headquartered in Ann Arbor, MI. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Vanderbilt University | College/University | Graduate Degree | |
GLENMARK PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
The University of Texas at Austin | College/University | Undergraduate Degree Undergraduate Degree | |
University of Hawai'i at Hilo
University of Hawai'i at Hilo Other Consumer ServicesConsumer Services University of Hawai'i at Hilo engages in the provision of services relating to higher education. It offers bachelor’s degrees, minors, master’s degrees, doctoral degrees, certificate programs, graduate certificate programs, and distance learning. The company was founded in 1947 and is headquartered in Hilo, HI. | College/University | Doctorate Degree | |
University of Maryland | College/University | Doctorate Degree Doctorate Degree | |
CELLECTIS S.A. | Pharmaceuticals: Major | Director/Board Member | |
DBV TECHNOLOGIES | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
University of Milan | College/University | Doctorate Degree | |
Weizmann Institute of Science | College/University | Director/Board Member | |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal | |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
SHVMS, LLC
SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | Investment Managers | Private Equity Investor Private Equity Investor | |
CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Novartis Pharma SAS
Novartis Pharma SAS Pharmaceuticals: MajorHealth Technology Novartis Pharma SAS wholesales and distributes pharmaceutical products. It offers generic and branded drugs and medicines. The company is headquartered in Rueil-Malmaison, France. | Pharmaceuticals: Major | Chief Executive Officer | |
Shionogi, Inc.
Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Part of Shionogi & Co., Ltd., Shionogi, Inc. is a pharmaceutical company based in Florham Park, NJ. Since 1878, the company has been utilizing science to address health challenges and has discovered several novel antibiotics and medications for HIV and influenza. Shionogi conducts ongoing research into established products and new antibiotic compounds, as well as developing an investigational antiviral for COVID-19. The company is committed to pursuing discovery through partnerships, including collaboration with scientists through investigator-initiated research. Shionogi is dedicated to advancing the greater good by developing, partnering, and commercializing medicine to treat serious unmet medical needs in infectious disease and other areas of high medical need including neurology and cardiovascular disease. Nathan McCutcheon has been the CEO of the company since 2019. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SERES THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
The Leonard N Stern School of Business | College/University | Masters Business Admin | |
IMMUNEERING CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
BEIGENE, LTD. | Pharmaceuticals: Major | Director/Board Member | |
NEON THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Xiangya Hospital Central South University | College/University | Doctorate Degree | |
BoxCar Partners LLC | Founder | ||
BeyondSpring Pharmaceuticals, Inc.
BeyondSpring Pharmaceuticals, Inc. BiotechnologyHealth Technology Part of BeyondSpring, Inc., BeyondSpring Pharmaceuticals, Inc. is a clinical-stage bio-pharmaceutical company that develops innovative immuno-oncology cancer therapies. The company is based in New York, NY. The company has a robust pipeline from internal development and collaboration with the University of Washington in de novo drug discovery using a ubiquitination platform. The CEO of the company is Lan Huang. | Biotechnology | Director/Board Member | |
Breast Cancer International Research Group Ltd. | Founder | ||
BEYONDSPRING INC. | Pharmaceuticals: Major | Director/Board Member | |
Aadi Subsidiary, Inc.
Aadi Subsidiary, Inc. BiotechnologyHealth Technology Aadi Subsidiary, Inc. engages in biopharmaceutical company. Its therapeutic programs include pulmonary arterial hypertension, pediatric solid tumors, solid tumors with mTOR activation and mitochondrial disease. The company was founded by Neil Desai and is headquartered in Pacific Palisades, CA. | Biotechnology | Chief Executive Officer | |
Intima Bioscience, Inc.
Intima Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Intima Bioscience, Inc. is a bioscience company that is advancing checkpoint cell therapy for solid tumors with curative intent. The private company is based in New York, NY. The company combines the use of patients' own immune cells with immune checkpoint targeting. Intima is currently running a phase 1/2 clinical study of its checkpoint cell therapy, which targets the immune checkpoint cish in patients with gastrointestinal and colon cancers. Alessandro Riva has been the CEO of the company since 2021. | Pharmaceuticals: Major | Chief Executive Officer | |
Deirdres House | Director/Board Member | ||
MJH Healthcare Holdings LLC
MJH Healthcare Holdings LLC Internet Software/ServicesTechnology Services MJH Healthcare Holdings LLC operates as a medical media company. Its services include creative, interactive, live events, clinical communication, promotional education, and market access. The company is headquartered in Cranbury, NJ. | Internet Software/Services | Director/Board Member | |
CENTURY THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ichnos Sciences, Inc. operates as a biotechnology company. It provides curative therapies that extend human life. The company was founded in 2019 and is headquartered in Paramus, NJ. | Miscellaneous Commercial Services | Chief Executive Officer | |
Asylia Therapeutics, Inc.
Asylia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Asylia Therapeutics, Inc. is a private biotechnology company founded in 2019 by Richard Jones, Robert Z. Orlowski, and Ronald A. DePinho. The company is based in Houston, TX. Asylia Therapeutics is focused on developing novel immune modulating therapies for cancer and autoimmune diseases. The company's drug pipeline is capable of modulating antigen presentation to the immune system, which has produced anti-tumor responses across multiple cancer models. The company is supported by a $3 million grant from the Cancer Prevention & Research Institute of Texas. The CEO is Karthik Radhakrishnan. | Pharmaceuticals: Major | President Director/Board Member | |
Sporos Bioventures, Inc.
Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Sporos Bioventures, Inc. is a private biopharmaceutical company based in Houston, TX. Sporos Bioventures, Inc. aims to transform the drug development process by identifying novel disease mechanisms and strategically deploying talent, capital, and access to operational resources to catalyze the development of breakthrough medicines. Sporos' current pipeline is diversified across three business units and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. The company provides centralized expertise, resources, and core infrastructure so that the portfolio companies can focus primarily on their research development programs. The company was founded by Peter Feinberg, Ronald A. DePinho, Jeno Gyuris, Joseph Kekst, Harold Levy, Alex M. Cranberg, Louis Feinberg, Michael S. Wyzga, Dana Levy, and the CEO is Stephen Rubino. | Medical/Nursing Services | Chief Executive Officer Founder | |
Cancer International Research Group | Founder | ||
AADI BIOSCIENCE, INC. | Biotechnology | Chief Executive Officer |
Statistics
International
United States | 38 |
France | 6 |
Switzerland | 3 |
India | 2 |
Italy | 2 |
Sectoral
Health Technology | 31 |
Consumer Services | 10 |
Finance | 3 |
Health Services | 3 |
Commercial Services | 3 |
Operational
Director/Board Member | 59 |
Corporate Officer/Principal | 31 |
Independent Dir/Board Member | 17 |
Chief Executive Officer | 16 |
President | 13 |
Most connected contacts
Insiders | |
---|---|
Simon Pedder | 19 |
Elan Ezickson | 17 |
Dennis McWilliams | 17 |
Alessandro Riva | 14 |
Rainer Boehm | 12 |
Brendan Delaney | 11 |
Meryl Zausner | 10 |
Pharis Mohideen | 9 |
Jian Ming Mei | 9 |
Casey Cunningham | 8 |
Ethan Hu | 7 |
Joseph Kekst | 7 |
Vincent Sandanayaka | 1 |
- Stock Market
- Insiders
- Jaime Escobedo
- Company connections